STEP TEENS trial: Semaglutide in adolescents reduces weight and improves liver health
Two new secondary analyses of the STEP TEENS trial presented at this year's European Congress on Obesity have reported that almost half...
STEP TEENS trial: Semaglutide in adolescents reduces weight and improves liver health
Anti-obesity medications remain prohibitively expensive
Top 10 most read articles on Bariatric News - September 2022
Semaglutide is clinically effective for weight loss at three and six months
NICE recommends semaglutide for obesity treatment
STEP 2: Semaglutide aids weight loss in type 2 diabetics
Semaglutide plus intensive behavioural therapy showed triple weight loss vs placebo
STEP outcomes: Semaglutide could be ‘gamechanger’ in battle against obesity